Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Invernizzi

Showing results (241-250 of 420) with videos related to

Pageof 42
Sort By:
Hepatology (Baltimore, Md.)|August 5, 2017
A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammationHaiyan Zhang, Min Lian, Jun Zhang, et al.
Cancer Letters|November 30, 2016
Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growthChad Hall, Laurent Ehrlich, Julie Venter, et al.
Gastroenterology|August 10, 2004
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environmentCarlo Selmi, Marlyn J Mayo, Nancy Bach, et al.
Journal of Autoimmunity|December 27, 2011
Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditisLuca Persani, Marco Bonomi, Ana Lleo, et al.
Hepatology (Baltimore, Md.)|July 2, 2025
Retraction: Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2 -/- mice and human cholangiocarcinoma tumorigenesisLindsey Kennedy, Laura Hargrove, Jennifer Demieville, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 26, 2018
Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2<sup>-/-</sup> mice and human primary sclerosing cholangitisFanyin Meng, Lindsey Kennedy, Laura Hargrove, et al.
Hepatology (Baltimore, Md.)|May 14, 2026
Definition, diagnosis, and treatment of primary biliary cholangitis - autoimmune hepatitis (PBC-AIH) variant: An international expert delphi consensusAlessio Gerussi, Marcial Sebode, Eugenia Nofit, et al.
Epigenetics|September 25, 2010
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosisMichelle M Mitchell, Ana Lleo, Luca Zammataro, et al.
Frontiers in Immunology|September 5, 2022
Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitisBin Liu, Guo-Xiang Yang, Ying Sun, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 16, 2019
Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2<sup>-/-</sup> miceVik Meadows, Lindsey Kennedy, Laura Hargrove, et al.
Pageof 42

Showing results (241-250 of 420) with videos related to

Sort By:
Pageof 42
Hepatology (Baltimore, Md.)|August 5, 2017
A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammationHaiyan Zhang, Min Lian, Jun Zhang, et al.
Cancer Letters|November 30, 2016
Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growthChad Hall, Laurent Ehrlich, Julie Venter, et al.
Gastroenterology|August 10, 2004
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environmentCarlo Selmi, Marlyn J Mayo, Nancy Bach, et al.
Journal of Autoimmunity|December 27, 2011
Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditisLuca Persani, Marco Bonomi, Ana Lleo, et al.
Hepatology (Baltimore, Md.)|July 2, 2025
Retraction: Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2 -/- mice and human cholangiocarcinoma tumorigenesisLindsey Kennedy, Laura Hargrove, Jennifer Demieville, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 26, 2018
Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2<sup>-/-</sup> mice and human primary sclerosing cholangitisFanyin Meng, Lindsey Kennedy, Laura Hargrove, et al.
Hepatology (Baltimore, Md.)|May 14, 2026
Definition, diagnosis, and treatment of primary biliary cholangitis - autoimmune hepatitis (PBC-AIH) variant: An international expert delphi consensusAlessio Gerussi, Marcial Sebode, Eugenia Nofit, et al.
Epigenetics|September 25, 2010
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosisMichelle M Mitchell, Ana Lleo, Luca Zammataro, et al.
Frontiers in Immunology|September 5, 2022
Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitisBin Liu, Guo-Xiang Yang, Ying Sun, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 16, 2019
Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2<sup>-/-</sup> miceVik Meadows, Lindsey Kennedy, Laura Hargrove, et al.
Pageof 42